People: ThermoGenesis Corp (KOOL.PH)
KOOL.PH on Philadelphia Stock Exchange
2.03USD
26 Oct 2011
2.03USD
26 Oct 2011
Price Change (% chg)
$-0.05 (-5.88%)
$-0.05 (-5.88%)
Prev Close
$2.03
$2.03
Open
--
--
Day's High
$0.86
$0.86
Day's Low
$0.80
$0.80
Volume
60,991
60,991
Avg. Vol
45,143
45,143
52-wk High
$1.43
$1.43
52-wk Low
$0.70
$0.70
Summary
| Name | Age | Since | Current Position |
|---|---|---|---|
Craig Moore |
68 | 2012 | Independent Chairman of the Board |
Matthew Plavan |
2013 | Chief Executive Officer, Director | |
Dan Bessey |
48 | 2013 | Chief Financial Officer |
Harold Baker |
63 | 2012 | Vice President - Commercial Operations & Marketing |
Kevin Cooksy |
50 | 2012 | Vice President - Corporate Development & Scientific Affairs |
Ken Pappa |
51 | 2012 | Vice President - Manufacturing and Engineering |
David Carter |
73 | 2010 | Independent Director |
Patrick McEnany |
65 | 2012 | Independent Director |
Robin Stracey |
54 | 2011 | Independent Director |
Biographies
| Name | Description |
|---|---|
Craig Moore |
Mr. Craig W. Moore is Independent Chairman of the Board of ThermoGenesis Corp. Mr. Moore was appointed to the Board of Directors in December 2009 and Chairman in January 2012. Mr. Moore has served as director of NxStage (NXTM) since 2002 and currently serves as chairman of their Compensation Committee and a member of their Audit Committee. From 1986 to 2001, Mr. Moore was Chairman of the Board of Directors and Chief Executive Officer at Everest Healthcare Services Corporation, a provider of dialysis and contract services. Since 2001, Mr. Moore has acted as a consultant to various companies in the healthcare services industry. Mr. Moore also spent 13 years with American Hospital Supply/Baxter Healthcare, where he held senior management positions in sales, marketing and business development. Mr. Moore served as a director of Biologic System Corporation (BLSC) from 1992 thru 2006. Mr. Moore also serves as a director on several private company boards. |
Matthew Plavan |
Mr. Matthew T. Plavan, CPA, is Chief Executive Officer, Director of ThermoGenesis Corp., since January 2012. He served as Chief Financial Officer of the Company. Prior to being named Chief Executive Officer, he served as Chief Financial Officer and Executive Vice President, Business Development and has also served as interim Chief Executive Officer and Chief Operating Officer. Mr. Plavan joined ThermoGenesis in May of 2005 as Chief Financial Officer. Before joining the Company, Mr. Plavan served from 2002 to 2005 as Chief Financial Officer of StrionAir, Inc., an air purification product development and marketing company. Prior to that, Mr. Plavan has served in a number of key financial and operating leadership roles and was an audit manager in the Audit and Risk Advisory Services group of Ernst & Young LLP. Mr. Plavan became a Certified Public Accountant in 1992. Mr. Plavan earned his bachelor's degree in business economics from the University of California at Santa Barbara. |
Dan Bessey |
Mr. Dan T. Bessey has been appointed as Chief Financial Officer of ThermoGenesis Corporation, effective March 26, 2013. Mr. Bessey previously served from 2008 to 2012 as Vice President and Chief Financial Officer of SureWest Communications, a telecommunications company providing voice, video and data services to residential and commercial customers. Mr. Bessey was with SureWest Communications since 1995 and served in a number of key financial leadership roles including Vice President of Finance, Controller and Director of Corporate Finance. Prior to joining SureWest Communications, Mr. Bessey was with Ernst & Young, LLP. Mr. Bessey is a Certified Public Accountant and has a B.S. degree in Business Administration with a concentration in Accountancy from California State University – Sacramento, where he graduated Magna Cum Laude. |
Harold Baker |
Mr. Harold Baker is Vice President - Commercial Operations & Marketing of ThermoGenesis Corp. He joined ThermoGenesis in August 2009 as Vice President of Sales, was appointed Vice President of Commercial Operations in November 2009 and Vice President of Commercial Operations and Marketing in January 2012. From 2006 to 2009, Mr. Baker was Vice President, Global Sales for Hygenic Corporation. He was at Pall Corporation serving as Senior Vice President, Global Marketing from 2004 to 2005 and Senior Vice President, US Commercial Operations from 2001 to 2004. Mr. Baker has a BA in Political Science from Miami University (Oxford, Ohio) and a MA in Political Science from Kent State University. |
Kevin Cooksy |
Mr. Kevin D. Cooksy is Vice President - Corporate Development & Scientific Affairs of ThermoGenesis Corp. Mr. Cooksy joined ThermoGenesis in August of 2011 as Vice President, Business Development and in January 2012 assumed the role of Vice President of Corporate Development, Scientific and Regulatory Affairs. In September 2012, he transitioned to Vice President Corporate Development and Scientific Affairs. Prior to joining ThermoGenesis, from 2007 to 2010 Mr. Cooksy was Vice President, Business Development for Perlegen Sciences. From 2005 to 2007 Mr. Cooksy held management positions in Corporate Development and Global Marketing for Agilent Technologies. Previously, Mr. Cooksy held leadership roles in New Business Opportunities at Nektar (Inhale) Therapeutics and Corporate Development at J&W Scientific. Mr. Cooksy obtained a BS in Chemistry from Northern Illinois University, an MBA from Lake Forest College, and a Juris Doctor from the McGeorge School of Law at the University of the Pacific. |
Ken Pappa |
Mr. Ken Pappa is Vice President - Manufacturing and Engineering of ThermoGenesis Corp. He joined ThermoGenesis in April 2006 as Director of Finance and has held the following positions: Senior Director of Finance, Senior Director of Internal Operations, Vice President of Manufacturing and Vice President of Manufacturing and Engineering. In January 2012, he assumed the role of Vice President of Manufacturing, Engineering and Quality and in October 2012 he transitioned to Vice President of Manufacturing and Engineering. Prior to joining ThermoGenesis, Mr. Pappa held various positions with Hewlett Packard–Agilent Technologies including Manufacturing Controller and Senior Operations Manager. Mr. Pappa has a BS in Business Administration-Accounting and a MBA from San Jose State University. Mr. Pappa became a Certified Public Accountant in 1988. |
David Carter |
Mr. David W. Carter is Independent Director of ThermoGenesis Corp. Mr. Carter is the Chief Executive Officer of Maji Therapeutics and also serves as President of DaCart, Inc., a business consulting company which he co-founded in 2006. Mr. Carter was the Chief Executive Officer of Origen Therapeutics, a company that develops technology for producing fully human sequence polyclonal antibodies from November 2009 until July 2012. Previously, Mr. Carter had served as Chairman of the board of Xenogen from November 1997 through August 2006, and as Xenogen's Chief Executive Officer from April 2003 through August 2006. Mr. Carter was an audit committee member from 1997 to 2011 and a director of ImmunoGen, Inc., (IMGN), Caliper Life Sciences (CALP) and Origen Therapeutics, Inc. Mr. Carter received a B.A. in history and an M.B.A. from Indiana University. |
Patrick McEnany |
Mr. Patrick J. McEnany is Independent Director of ThermoGenesis Corp. Mr. McEnany rejoined the Board of Directors in 1997. Mr. McEnany is co-founder, Chairman, President and Chief Executive Officer of Catalyst Pharmaceutical Partners, Inc., a specialty pharmaceutical company. Mr. McEnany has served as Catalyst's Chief Executive Officer and a director since its formation in January 2002. From 1991 to April of 1997, Mr. McEnany was Chairman and President of Royce Laboratories, Inc., a Miami, Florida based manufacturer of generic prescription drugs. From 1997 to 1998, after the merger of Royce Laboratories, Inc., into Watson Pharmaceuticals, Inc., Mr. McEnany served as President of the wholly-owned Royce Laboratories subsidiary and Vice President of Corporate Development for Watson Pharmaceuticals, Inc. From 1993 through 1997, he also served as Vice Chairman and director of the National Association of Pharmaceutical Manufacturers. He currently serves on the Board of Directors for the Jackson Memorial Hospital Foundation and until 2012 for Renal CarePartners, Inc. |
Robin Stracey |
Mr. Robin C. Stracey is Independent Director of ThermoGenesis Corp. Mr. Stracey was appointed to the Board of Directors on July 29, 2011. In July 2012, Mr. Stracey became Director, President and Chief Executive Officer of Integrated Fluidics, Inc., a privately-held microfluidics company. From December 2007 to April 2012 he was the President and Chief Executive Officer of Cantimer Incorporated, a privately-held biosensor company at which he remains on the Board of Directors. From November 2003 to March 2007, Mr. Stracey was Director, President and Chief Executive Officer of Applied Imaging Corporation, a publicly-traded, computer-aided diagnostics company that is now part of Danaher Corporation. Previously, Mr. Stracey was the Vice President and General Manager of a Chromatography and Mass Spectrometry business unit of Thermo Electron Corporation, now Thermo Fisher Scientific, the supplier of laboratory equipment and reagents to life scientists. He also served as a Corporate Vice President at Dade Behring Inc., a supplier of clinical diagnostic products that is now part of Siemens Healthcare. Mr. Stracey has a Bachelor of Science degree with honors from the University of Nottingham in the United Kingdom and is a graduate of the Executive Program at the Stanford University Graduate School of Business. |
Basic Compensation
| Name | Fiscal Year Total |
|---|---|
Craig Moore |
-- |
Matthew Plavan |
464,000 |
Dan Bessey |
-- |
Harold Baker |
455,000 |
Kevin Cooksy |
279,000 |
Ken Pappa |
338,000 |
David Carter |
-- |
Patrick McEnany |
-- |
Robin Stracey |
-- |
As Of 29 Jun 2012
Options Compensation
| Name | Options | Value |
|---|---|---|
Craig Moore |
0 | 0 |
Matthew Plavan |
90,000 | 10,000 |
Dan Bessey |
0 | 0 |
Harold Baker |
0 | 0 |
Kevin Cooksy |
0 | 0 |
Ken Pappa |
0 | 0 |
David Carter |
0 | 0 |
Patrick McEnany |
0 | 0 |
Robin Stracey |
0 | 0 |
| Name | Shares Traded | Price |
|---|---|---|
STRACEY ROBIN C |
5,294 | $0.85 |
MOORE CRAIG W |
6,471 | $0.85 |
MOORE CRAIG W |
25,000 | $1.02 |
AUDITORE-HARGREAVES KAREN |
50,000 | $0.00 |
BAKER HAROLD |
50,000 | $0.00 |
RAO MAHENDRA S |
31,250 | $0.00 |
ARTILES JORGE |
50,000 | $0.00 |
ENGLE J MELVILLE |
100,000 | $0.00 |
PLAVAN MATTHEW T |
75,000 | $0.00 |
RAO MAHENDRA S |
25,000 | $1.98 |
PLAVAN MATTHEW T |
30,000 | $2.25 |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
